Requires certain health plans to include coverage for fertility preservation services. (BDR 57-915)
AB 428 requires a broad set of health coverage arrangements in Nevada to include medically necessary fertility preservation services for insureds diagnosed with breast or ovarian cancer. The bill applies to individual and group health insurance policies, health benefit plans, benefit contracts, health care plans, and managed care arrangements, including Medicaid and certain public employee coverage. Covered services must be consistent with established medical practice or guidelines from the American Society for Reproductive Medicine or the American Society of Clinical Oncology, and the coverage applies when the cancer itself or its treatment may directly or indirectly cause infertility. The bill also provides that policies and plans issued, delivered, or renewed on or after the effective date must be read as including the required coverage, and conflicting policy language is void.
The bill creates a religious-affiliation exception for insurers, societies, hospitals or medical services corporations, HMOs, and managed care organizations that object on religious grounds, so long as they provide written notice of the refusal to cover the service. It also authorizes the Insurance Commissioner to enforce compliance, including suspension or revocation of certificates of authority for noncompliant health maintenance organizations and other insurers. For Medicaid, the Department of Health and Human Services must seek any needed federal waiver or state plan amendment, and the bill includes a General Fund appropriation and additional spending authority to support implementation, including system upgrades and vendor costs.
AB 428 appears to have been generally well received in the Legislature, passing the Assembly 38-4 and the Senate 20-0. The strong final votes suggest broad bipartisan support for expanding fertility preservation coverage for cancer patients, especially given the bill’s focus on medically necessary care and its application across both private and public coverage markets. The absence of committee transcript excerpts limits insight into detailed debate, but the voting history indicates little organized opposition at final passage.
The main points of contention are likely to have centered on cost, administrative implementation, and the scope of mandated coverage, particularly for Medicaid and public plans. Another likely issue is the religious exemption, which balances the coverage mandate against objections from faith-affiliated insurers and similar entities. The bill also relies on outside medical guidelines to define covered services and on federal approval for Medicaid funding, which may raise implementation questions even where policy support is strong.
AB 428 amends multiple chapters of Nevada insurance and health law to require fertility preservation coverage for breast and ovarian cancer patients across individual, group, association, hospital/medical services corporation, HMO, managed care, public employee, and Medicaid coverage structures. It also adds enforcement authority for the Insurance Commissioner, directs the Department of Health and Human Services to pursue federal Medicaid approval, and appropriates state funds for implementation. The bill voids conflicting policy terms and sets an effective date structure that allows administrative preparation before the substantive coverage mandate takes effect.
The overall sentiment around AB 428 appears strongly favorable. The bill passed both chambers by wide margins, including unanimous Senate final passage, indicating broad legislative support for expanding cancer-related fertility preservation benefits. The available record does not show committee testimony, but the final votes suggest the measure was viewed as a targeted health coverage expansion with limited partisan resistance.
The likely areas of contention are the cost of mandated benefits, especially for Medicaid and public plans, and the administrative burden of updating systems and coverage rules. Religious-affiliated insurers and similar entities are given an exemption if they object on religious grounds, which suggests that accommodation for faith-based organizations was a notable issue in drafting. Another possible point of debate is the bill’s reliance on medical society guidelines and the need for federal approval to secure Medicaid funding, both of which affect how broadly and quickly the mandate can be implemented.